| Release | Press release to attorney generals Pharma paying $600 million in fines and other payments for the criminal charge of misbranding their product OxyContin and the Federal Drug Administration being unresponsive as shown below, please convene a review panel to review the FDA's involvement in the criminal activities of Purdue Pharma in their marketing of OxyContin ... |
| Article | Readington family finds justice, but seeks more Mother, young son of woman who died from OxyContin complications prepare for journey |
| "Marianne Skolek has a long trip planned next month, from her home in Readington to a federal courthouse in Roanoke, Va. ..." | |
| Article | Preliminary Study Suggests Illegal Opioid Analgesic Medications Not Obtained Through Internet Sources: Presented at AAPM |
| I guess if you mass manufacture the drug so it's in plentiful supply on the streets, it only seems logical that you would conduct a study on how the abusers are getting the drug. | |
| Article | OxyContin maker settles suit for $75M |
| "Agreement with Purdue Pahram includes more than 1,100 lawsuits filed on the Island" | |
| Article | Purdue Pharma faces criminal charges |
| "Jury Eyes RX Bigs in OxyContin Coverup" | |
| Article | "Drug Deals" |
| Published January, 29, 2004 in the Orlando Weekly by Bob Whitby | |
| Letter | "Don't Forget The Patients" response from Purdue's executive vice president and chief scientific officer |
| Sent January 22, 2004 | |
| Letter | Letter from Senator Corzine to Representative Ferguson requesting I testify at subcommittee hearing! |
| Sent December 15, 2003 | |
| Article | "Mom stares down drug company" |
| Published December 14, 2003 in the Express Times | |
| Research | Conspiracy - You Be The Judge |
| A consensus on pain relief | |
| Research | Pseudo-Addiction |
| Although the pseudo-addiction concept lacks significant scientific support – it has become widely accepted within the pain-physician community. | |
| Article | "OxyContin Has a New Enemy" |
| Published September 3, 2002 in the Express-Times | |
| "A chilling attempt at damage control" |
|
| Published 3/5/2003 in the Star Ledger discussing a conference on pain medications at Columbia University's National Center for Addiction and Substance Abuse in New York City |
|
| Article | The $2 billion apology letter from Purdue Pharma |
| A Purdue Pharma response to "A chilling attempt at damage control" published March 18, 2003 in the Star-Ledger | |
| Article | "Chronic Opioid Treatment, Addiction and Pseudo-Addiction in Patients With Chronic Pain" |
| Published February, 2003 in the Psychiatric Times, Vol. XX Issue 2 | |
| Article | "Strong dose of hype for OxyContin inexcusable Series" |
| Published November 2, 2003in the St. Petersburg Times | |
| Article | "New trial begins for '01 armed robbery suspect; State says pair carefully planned and executed the drug robbery" |
| Published November 18, 2003 in the Columbus Ledger-Enquirer | |
| Article | "Team 8 Investigates - Illegal narcotics sold online" |
| WTNH - November 18, 2003 | |
| Article | "Drug burglar may be caught blue-handed" |
| Published by the Tribune | |
| Article | "Purdue Pharma Pulls OxyContin Ads" |
| Published January 25, 2003 on "Painandthelaw.com" | |
| Letter to FDA Commissioner |
|
| March 12, 2003 point-by-point response to his earlier letter to me regarding the FDA's approval of OxyContin |
|
| Purdue Pharma and Mass Marketing of OxyContin |
|
| February 4, 2003 letter to Mr. Thomas W. Abrams, R.Ph,, MBA, Director Division of Drug Marketing Advertising and Communication |
|
| Purdue Pharma and OxyContin - Purdue Pharma and Palladone |
|
| October 20, 2003 letter to U.S. Senators, All Attorney Generals and Associated Press Offices |
|
| RE: Conflict of Interest Purdue Pharma and the FDA |
|
| February 8, 2004 letter to all U.S. Attorney Generals |
|
| Purdue Pharma – Oxycontin |
|
| March 12, 2003 letter to Mark McClellan, M.D. Commissioner Food and Drug Administration U.S. Department of Health and Human Services |
|
| Mass Marketing, Mis-Prescription and Need for Regulation of Oxycontin |
|
| January 1, 2003 letter to all U.S. major newspapers and U.S. Senators |
|